Healthcare disease pipeline guide Constipation Pipeline Review Analysis 2019

Posted on 2019-10-01 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, US, 2019-Oct-01 — /EPR Network/ —Market Research Hub (MRH) has recently uploaded a new study titled “Constipation-Pipeline Review, H2 2019” to its broad online storehouse. The global Constipation Market, conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the prevailing status across the global Constipation Market.

Get Sample Copy@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2519480

Constipation – Pipeline Review, H2 2019

Summary

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Constipation – Pipeline Review, H2 2019, provides an overview of the Constipation (Gastrointestinal) pipeline landscape.

Constipation refers to the infrequent or difficult passing of stool. Constipation occurs when bowel movements become difficult or less frequent. Symptoms of constipation include swollen abdomen or abdominal pain, pain and vomiting. The predisposing factors include eating disorders, irritable bowel syndrome, and hypothyroidism, overuse of laxatives (stool softeners) which, over time, weaken the bowel muscles, stress, inadequate water intake and inadequate fiber in the diet. Treatment includes use of laxatives and proper lifestyle.

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Constipation – Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Constipation (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Constipation (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Constipation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Unknown stages are 3, 2, 7, 2, 3 and 1 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.

Constipation (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Constipation (Gastrointestinal).
– The pipeline guide reviews pipeline therapeutics for Constipation (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Constipation (Gastrointestinal) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Constipation (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Constipation (Gastrointestinal)

Request TOC of the Report @ https://www.marketresearchhub.com/report/constipation-pipeline-review-h2-2019-report.html

Table of Contents

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Constipation – Overview
Constipation – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Constipation – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Constipation – Companies Involved in Therapeutics Development
Allergan Plc
Ardelyx Inc
Bausch Health Companies Inc
Braintree Laboratories Inc
Dong-A ST Co Ltd
Enterin Inc
Inhibikase Therapeutics Inc
Ironwood Pharmaceuticals Inc
Kissei Pharmaceutical Co Ltd
Mallinckrodt Plc
NGM Biopharmaceuticals Inc
RaQualia Pharma Inc
Renexxion LLC
Sanwa Kagaku Kenkyusho Co Ltd
Synthetic Biologics Inc
Yuhan Corp
Zensun (Shanghai) Sci & Tech Co Ltd
Constipation – Drug Profiles
5-BIOP – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biologic for Irritable Bowel Syndrome with Constipation – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BLI-400 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BLI-801 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DA-6886 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ENT-01 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IkT-148009 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lactulose 1 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
linaclotide – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lovastatin MR – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lubiprostone – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
mizagliflozin – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
naronapride – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NGM-282 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plecanatide – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RQ-00000010 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tenapanor – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
YH-12852 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZS-06 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Constipation – Dormant Projects
Constipation – Discontinued Products

Enquire about This Report @ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2519480

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Pharmaceuticals market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick